View Cart (0 items)
Pharmaceutical

J&J Recalls Prompt New Quality Control Position

August 19, 2010
/ Print / Reprints /
| Share More
/ Text Size+
Johnson & Johnson is creating a new position to oversee companywide quality, manufacturing and compliance issues and appointing chief quality officers for each of its three major business units, according to the Associated Press. J&J named corporate Vice President Ajit Shetty to oversee the push for quality improvements in its pharmaceutical, consumer products and medical device and diagnostics groups. Since September, the company has announced eight different recalls. They cover tens of millions of bottles of pain relievers Tylenol, Motrin and St. Joseph aspirin, allergy drug Benadryl, heartburn tablets Rolaids and Simply Sleep pills. The recalls involved products made at both a Fort Washington, Pa., factory shut down in April, plus another factory in Las Piedras, Puerto Rico. Food and Drug Administration inspections have uncovered problems at both those factories and a third one, in Lancaster, Pa., that''s run by McNeil''s joint venture with Merck & Co. The recalls involve problems from contamination with bacteria and a nauseating smell on containers to liquid medicines that may contain tiny metal shavings and products that may have the wrong amount of active ingredient.
You must login or register in order to post a comment.